NASDAQ$RGNX

REGENXBIO Inc · Q4 2018 earnings

Q4 2018 earnings · · Investor relations

Headline financials

Total Revenue

$40.8M

Previous: $2.04M+1898.9%
EPS (adj)

$0.11

Previous: -$0.51+121.6%
Capital Expenditures

$4.89M

Previous: $2.1M+132.7%
Free Cash Flow

-$9.03M

Previous: -$15.9M+43.3%
Net Income

$4.31M

Previous: -$16M+126.9%
Operating Income

$2.45M

Previous: -$16.6M+114.8%
Gross Profit

$37.9M

Previous: -$11.7M+422.9%
Cash & Equivalents

$75.6M

Previous: $46.7M+62.0%
Total Assets

$544M

Previous: $199M+173.7%
Stock-Based Comp

$4.89M

Previous: $2.8M+74.7%

Revenue & EPS history

REGENXBIO · Revenue · Quarterly

$40.8M

Q4 2018+1,898.9%vs Q4 2017
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2018

Historical avgQ4 2018

+0.8%

Avg return

Earnings day

+2.8%

Avg return

5 days after

+2.7%

Avg return

30 days after

57%

24 / 42 earnings

Positive

+28.0%

Q4 2017

Best reaction

-37.8%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-37.8%-43.8%
Q4 2025-4.7%+8.3%-6.7%
Q3 2025-3.6%-0.5%+13.4%
Q1 2025+2.9%+11.5%+28.0%
Q4 2024+2.6%+29.8%-10.1%
Q3 2024+25.4%+29.6%+7.4%
Q2 2024-8.5%-10.9%-14.2%
Q1 2024-7.5%-7.2%-17.0%
Q4 2023+8.5%+15.5%+14.9%
Q3 2023+2.3%+7.9%+19.1%
Q2 2023-8.7%-8.4%-5.3%
Q1 2023+2.2%-5.3%+1.2%
Q4 2022+10.0%+11.2%-17.6%
Q3 2022-14.5%-14.2%+0.1%
Q2 2022+9.2%+9.4%-6.9%
Q1 2022-14.2%-29.1%-19.1%
Q4 2021+11.1%+5.3%+26.6%
Q3 2021+4.4%+8.0%-12.5%
Q2 2021+0.1%+0.4%+6.9%
Q1 2021+4.8%+8.8%+7.4%
Q4 2020+1.0%-2.4%-16.6%
Q3 2020+1.1%+15.0%+32.0%
Q2 2020-3.4%-2.5%-16.9%
Q1 2020-5.5%-2.0%-9.5%
Q4 2019-14.8%-15.8%-28.7%
Q3 2019-2.6%+7.5%+17.3%
Q2 2019+0.6%-8.5%-22.5%
Q1 2019-12.8%-12.5%-11.7%
Q4 2018-2.2%+7.0%+8.3%
Q3 2018-1.0%-10.0%-24.7%
Q2 2018-5.8%-6.6%+4.4%
Q1 2018+13.2%+24.0%+42.8%
Q4 2017+28.0%+22.9%-3.4%
Q3 2017+0.9%+0.9%+19.6%
Q2 2017+11.8%+12.4%+33.3%
Q1 2017-4.9%+0.8%+9.5%
Q4 2016+6.6%+2.5%-10.2%
Q3 2016+24.6%+28.5%+20.7%
Q2 2016+0.8%+21.3%+41.5%
Q1 2016-3.6%
Q4 2015+1.8%
Q3 2015+14.0%
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro